BNP/CALL/ASTRAZENECA/12000/0.1/20.12.24 Share Price

Warrant

DE000PC3BU09

Market Closed - Boerse Frankfurt Warrants 08:51:09 17/05/2024 pm IST
1.29 EUR -1.53% Intraday chart for BNP/CALL/ASTRAZENECA/12000/0.1/20.12.24
Current month+0.78%
1 month+86.96%
Date Price Change
17/24/17 1.29 -1.53%
16/24/16 1.31 -5.07%
15/24/15 1.38 -4.17%
14/24/14 1.44 -1.37%
13/24/13 1.46 -5.19%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 08:51 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying ASTRAZENECA PLC
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PC3BU0
ISINDE000PC3BU09
Date issued 16/01/2024
Strike 12,000 p
Maturity 20/12/2024 (217 Days)
Parity 10 : 1
Emission price 0.62
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 1.57
Lowest since issue 0.2
Delta0.62x
Omega 6.854
Premium8.17x
Gearing11.01x
Moneyness 1.009
Difference Strike -110 p
Difference Strike %-0.92%
Spread 0.01
Spread %0.78%
Theoretical value 1.295
Implied Volatility 23.35 %
Total Loss Probability 44.81 %
Intrinsic value 0.1286
Present value 1.166
Break even 13,108.07 €
Theta-0.02x
Vega0.04x
Rho0.04x

Company Profile

AstraZeneca PLC is one of the world's leading pharmaceutical groups. Net sales break down by source of income as follows: - product sales (95.6%). Net sales break down by treatment area between oncology (39.2%), cardiovascular, renal and metabolic diseases (24.2%), respiratory and autoimmune diseases (13.9%), and other (22.7%; inflammatory diseases, neurological diseases, gastrointestinal and infectious diseases); - collaboration revenue (4.4%). Net sales are distributed geographically as follows: the United Kingdom (7.4%), Europe (21.2%), America (45.3%) and Africa-Asia-Australia (26.1%).
Sector
-
More about the company

Ratings for AstraZeneca PLC

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: AstraZeneca PLC

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
23
Last Close Price
153.9 USD
Average target price
167.6 USD
Spread / Average Target
+8.90%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW